GlassScriptPhysician profile
DO-Yeon Cho
NPI 1104051408
$19,408.05
in general payments reported to CMS, 2019-2025
20 companies · $9,654 in 2025
The $9,654 reported for 2025 was more than what 97% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,963 · 2020: $388 · 2021: $894 · 2022: $1,066 · 2023: $2,392 · 2024: $3,052 · 2025: $9,654.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,343 · Food and Beverage: $5,219 · Consulting Fee: $4,536.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,342.58 |
| Food and Beverage | $5,218.97 |
| Consulting Fee | $4,536.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $4,943.44 | 2024-2025 | |
| Medtronic, INC. | $3,598.66 | 2022-2025 | Fusion, Quadcut, Propel |
| Aerin Medical INC. | $3,433.96 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $2,337.08 | 2019-2025 | Dupixent |
| Optinose US, INC. | $2,055.76 | 2019-2021 | |
| 3-D Matrix, INC. | $918.63 | 2024-2025 | |
| Intersect Ent, INC. | $763.49 | 2019-2022 | |
| Acclarent, INC | $498.02 | 2021-2022 | |
| Spirair, INC. | $166.64 | 2024-2025 | Septalign |
| Neurent Medical Limited | $131.93 | 2025 | Neuromark System, Neuromark Radiofrequency Console |
| Biosense Webster, INC. | $114.32 | 2022 | |
| Ambu INC. | $105.14 | 2020 | |
| Glaxosmithkline, LLC. | $104.07 | 2025 | Nucala |
| Inspire Medical Systems, INC. | $98.20 | 2023 | Inspire |
| Stryker Corporation | $83.08 | 2023 | Medpor Titan, Scopis Ent |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $38.17 | 2020 | |
| Karl Storz Endoscopy-America | $17.46 | 2019 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw DO-Yeon Cho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.